A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
University of Colorado, Denver
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
AbbVie
Calibr, a division of Scripps Research
University of Colorado, Denver
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Hackensack Meridian Health
Beth Israel Deaconess Medical Center
Geneve TEAM Ambulances
CRISPR Therapeutics
University Hospital, Caen
University Hospital, Caen
Celgene
Novartis
National Institutes of Health Clinical Center (CC)
University Hospital, Toulouse
University of Nebraska
University of Rochester
University of Rochester
H. Lee Moffitt Cancer Center and Research Institute
Hospital Universitario Dr. Jose E. Gonzalez
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
PETHEMA Foundation
Wake Forest University Health Sciences
Thomas Jefferson University
Novartis
Dana-Farber Cancer Institute
Takeda
University of Illinois at Chicago
Centre Oscar Lambret
Institut Paoli-Calmettes
University of Chicago
Incyte Corporation
University of Miami
University of Nebraska
Massachusetts General Hospital
M.D. Anderson Cancer Center
Massachusetts General Hospital
Hoffmann-La Roche
Roswell Park Cancer Institute
Gamida Cell ltd
Columbia University
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
BeOne Medicines